Burning Rock Biotech Stock Pattern Recognition Stalled Pattern

BNR Stock  USD 16.01  -6.84  -29.93%   
Use the pattern recognition workspace to apply Stalled Pattern recognition and other studies to Burning Rock. It emphasizes pattern recognition signals tied to momentum and continuation while keeping volatility, risk, and performance context in view.

Recognition
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of forty-nine. The function did not return any valid pattern recognition events for the selected time horizon. The Stalled pattern represents a weakness and consolidation and Burning Rock Biotech possible reversal in trend.

Burning Rock Technical Analysis Modules

Most technical analysis of Burning Rock help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Burning from various momentum indicators to cycle indicators. When you analyze Burning charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the Peoples Republic of China. The company was incorporated in 2014 and is headquartered in Guangzhou, China. Burning Rock operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1394 people. The stock overview for Burning Rock summarizes business drivers, financial profile, and market behavior. The company is positioned within Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Current metrics include P/B of 2.15, profit margin of -22.49%. Burning Rock has a market cap of 172.37 M, ROE of -20.25%.

Methodology

Unless otherwise specified, financial data for Burning Rock Biotech is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Burning (USA Stocks:BNR) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Datasets used in this report incorporate public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Information may be standardized across formats and may reflect delayed updates. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Burning Rock Biotech may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Vlad Skutelnik - Macroaxis Contributor

Learn to be your own money manager

Tracking Burning Rock inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Pattern Recognition Now

   

Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
All  Next Launch Module

Burning Rock Biotech pair trading

Pair trading with Burning Rock can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

Burning Rock Pair Trading

Burning Rock Biotech Pair Trading Analysis

When executing tax-loss harvesting on Burning Rock Biotech, the goal is to sell at a loss and immediately redeploy proceeds into a sufficiently different but highly correlated asset. This approach maintains Burning Rock's risk contribution to the portfolio while generating a realized tax loss.
Rolling correlation analysis for Burning Rock shows how its relationship with other instruments evolves over time. Correlations that spike toward +1 during market stress suggest that Burning Rock Biotech's diversification benefits may disappear precisely when they are most needed.
Correlation analysis and pair evaluation for Burning Rock can support hedging context. The approach can be applied within sectors or across broader universes.
Pair CorrelationCorrelation Matching

Additional Tools for Burning Stock Analysis

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stocks Directory
Find actively traded stocks across global markets